Back to Search Start Over

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: The Dominantly Inherited Alzheimer's Network Study

Authors :
O'Connor, Antoinette
Rice, Helen
Barnes, Josephine
Ryan, Natalie S.
Liu, Kathy Y.
Allegri, Ricardo Francisco
Berman, Sarah
Ringman, John M.
Cruchaga, Carlos
Farlow, Martin R.
Hassenstab, Jason
Lee, Jae-Hong
Perrin, Richard J.
Xiong, Chengjie
Gordon, Brian
Levey, Allan I.
Goate, Alison
Graff-Radford, Neil
Levin, Johannes
Jucker, Mathias
Benzinger, Tammie
McDade, Eric
Mori, Hiroshi
Noble, James M.
Schofield, Peter R.
Martins, Ralph N.
Salloway, Stephen
Chhatwal, Jasmeer
Morris, John C.
Bateman, Randall
Howard, Rob
Reeves, Suzanne
Fox, Nick C.
O'Connor, Antoinette
Rice, Helen
Barnes, Josephine
Ryan, Natalie S.
Liu, Kathy Y.
Allegri, Ricardo Francisco
Berman, Sarah
Ringman, John M.
Cruchaga, Carlos
Farlow, Martin R.
Hassenstab, Jason
Lee, Jae-Hong
Perrin, Richard J.
Xiong, Chengjie
Gordon, Brian
Levey, Allan I.
Goate, Alison
Graff-Radford, Neil
Levin, Johannes
Jucker, Mathias
Benzinger, Tammie
McDade, Eric
Mori, Hiroshi
Noble, James M.
Schofield, Peter R.
Martins, Ralph N.
Salloway, Stephen
Chhatwal, Jasmeer
Morris, John C.
Bateman, Randall
Howard, Rob
Reeves, Suzanne
Fox, Nick C.
Source :
Research outputs 2022 to 2026
Publication Year :
2023

Abstract

Behavioural changes and neuropsychiatric symptoms (NPS) commonly occur in Alzheimer’s disease (AD) but may not be recognised as AD-related when they are the presenting feature. NPS are important as they are associated with greater functional impairment, poorer quality of life, accelerated cognitive decline and worsened caregiver burden.1 Autosomal dominant AD (ADAD), although < 1% of total AD cases, provides a valuable opportunity to study the clinical heterogeneity of AD. The young age at onset reduces the prevalence of age-related comorbid pathologies and the near 100% penetrance of pathogenic mutations reduces the likelihood of misdiagnosis.2 Anxiety and depression commonly occur in ADAD family members, with increased levels of depression having been found among predementia female mutation carriers.3 Subsequent studies, however, have shown that anxiety and/or depression are common regardless of mutation status, occurring in almost one in three at-risk individuals, with one study reporting a higher rate of depression in non-carriers (17%) than asymptomatic carriers (5%).4 5 Despite the high frequency of NPS in ADAD families, relatively little is known about the proportion of ADAD cases who present with predominantly behavioural symptoms. Our aims were to assess the first reported clinical change in symptomatic ADAD, to compare presentations across genotypes, and to compare cognitive performance between behavioural and cognitive-led presentations.

Details

Database :
OAIster
Journal :
Research outputs 2022 to 2026
Notes :
application/pdf, Research outputs 2022 to 2026
Publication Type :
Electronic Resource
Accession number :
edsoai.on1380673464
Document Type :
Electronic Resource